UC Irvine News Brief: Clinical trial of UCI-created stem cell treatment opened to U.S., Canadian patients
Three people have already been enrolled in first-ever test of a human neural stem cell-based therapy for chronic spinal cord injury.
Three people have already been enrolled in first-ever test of a human neural stem cell-based therapy for chronic spinal cord injury.
Aileen Anderson and Brian Cummings of the Sue & Bill Gross Stem Cell Research Center collaborated with StemCells Inc. to develop the treatment for chronic spinal cord injury.
The treatment for people with spinal cord injury was created in the lab of UCI neurobiologist Hans Keirstead.
A therapy developed by Aileen Anderson and Brian Cummings of UC Irvine’s Sue & Bill Gross Stem Cell Research Center in collaboration with researchers at StemCells Inc. will be the basis of the world’s first clinical trial using human neural stem cells to treat spinal cord injury.
California Stem Cell Inc. has applied to the federal Food & Drug Administration to start a Phase I safety study on the treatment, created in collaboration with Hans Keirstead’s research group.
Subject with acute spinal cord injury joins groundbreaking Phase I study sponsored by Geron Corp. at Atlanta location.
Geron Corp. will conduct the world’s first clinical trial of a human embryonic stem cell-based therapy in patients with acute spinal cord injury.
Sequential-growth-factor therapy holds promise for improving recovery outcomes.
Across the country, myriad clinical trials of new cancer treatments are being conducted, but – according to Dr. Homayoon Sanati,…
The Chao Family Comprehensive Cancer Center at UC Irvine is the only cancer clinic in Orange County to be an…